logo
  

Henry Schein Acquires 70% Of EAssist Dental Solutions For Undisclosed Terms - Quick Facts

Healthcare solutions company Henry Schein, Inc. (HSIC) announced Tuesday that it has acquired a 70% ownership position in eAssist Dental Solutions, the developer of a leading and fast-growing virtual dental billing outsourcing service. Financial terms were not disclosed.

eAssist will help advance Henry Schein's mission to offer best-of-breed solutions to help dental practices operate more efficiently and profitably, freeing up practice resources to focus on patient care.

eAssist was founded in 2011 by James Anderson, DMD, and Sandy Odle to assist with billing challenges in his dental practices. Anderson will continue to manage the eAssist business as Chief Executive Officer, along with the current eAssist management team.

Henry Schein expects that eAssist will be slightly dilutive to the Company's 2021 financial results and to be accretive thereafter. Financial terms were not disclosed.

eAssist is currently designed to support dental practices of all sizes through technology supported by a network of dental billing professionals. In addition to its core dental billing service, newer offerings from eAssist include securing detailed patient eligibility information, billing certain dental procedures through medical insurance, and practice bookkeeping.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
MTD Products Inc. is recalling 1,774 units of walk-behind self-propelled lawn mowers for potential risk of fire hazard, a statement by the U.S. Consumer Product Safety Commission (CPSC) showed. The company said the lawn mower can leak fuel when it is stored in the upright (vertical) storage position to pose a fire hazard. Nike Inc. announced its plans to exit the Russian market completely following Russia's ongoing war against Ukraine, reports said. The sportswear major, with more than 100 stores in the country, had suspended operations there in March. Earlier in March, while suspending operations temporarily, the company had said its customers that it couldn't guarantee product shipments. The U.S. Food and Drug Administration unveiled its action plan to advance drug development for rare neurodegenerative diseases, including Amyotrophic Lateral Sclerosis or ALS, in five years. The FDA plans specific actions such as regulatory science initiatives, enhancements to existing programs and new policy initiatives for the purpose. It will use public-private partnerships...
Follow RTT